Current Committees:

• Board Member, Mindelio/Heros Biotech™

• Board Member, Maternal Infant Child and Youth Research Network 

• Community Member (Second Term), Health Canada Science Advisory Committee on Pest Control Products

Chief Operating Officer - One Yukon Coalition

2023 - Present (Calgary)

Director, Science - R-Zero

2021 - 2023 (Salt Lake City, USA)

​

Director, Clinical Programs - CleanSlate

2020 - 2021 (Toronto)

​

Director, Science - Aurora

2019 - 2020 (Calgary, Edmonton)

​

Team Lead, Project and Initiatives - Canadian Institutes of Health Research Institute of Neurosciences, Mental Health, and Addiction

2017 - 2018 (Calgary)

​

Manager - Training & Early Career Development, Industry and Technology Initiatives - Alberta Innovates

2015 - 2017 (Edmonton)

Postdoctoral Fellow - University of Toronto, and University of Calgary

2011 - 2015 (Calgary)

Executive Operations:

• Profit & Loss Accountability

• Audit Oversight

• Financial Operations

• Fundraising & Grantmaking

• Human Resources, Belonging and Performance Culture Stewardship

• Governance, Risk & Compliance

• Data Stewardship

• Program Strategy & Implementation

• Legal & Contract Oversight

• Go-to-Market Strategy Support

• Strategic Communication & Marketing Enablement​

Market Experience:​

• Growth Stages: Pre-Seed, Series A–C, Post-IPO

• Primary Markets: Canada, United States

• Secondary Markets: United Kingdom, Germany, Australia​

Investment Oversight:​

• $5-19 M Portfolios

• Scientific Due-Diligence, Mergers & Acquisition Support

• Strategic and Targeted Investments ​in Research, Technology, and Capacity Building

​

Domains and Partnerships:

• Local, Provincial, Territorial, and Federal Government Agencies 

• Indigenous Governments and Organizations

• Medium to Large Universities, Schools

• Startups and Scaleups

• Non-Profit, Charitable, and Community-Based, and Sports Promotion Organizations

• ​Molecular Biology Across Diverse Fields, Including Genetics, Neuroscience, Microbiology, Public Health, and Emerging Areas (Photonics) at the Intersection With Physics and Engineering.

​

Technology, Research & Development (R&D):

• Community Research

• Program Design & Delivery

• Partnership Development

• Technology Sourcing & Evaluation

• Clinical Trial Oversight (Phases I–III)

• Good Clinical Practices (GCP) and Pharmacovigilance

• Prototype Development, Efficacy and Safety Product Validation at Accredited Testing Laboratories (GMP/GLP-Compliant, BSL-2/3) under ASTM, ASHRAE, ISO, UL, and Nemko Standards

• Scientific & Technical Due Diligence

• Technology Sourcing & Evaluation

• Health Product Software-as-a-Service (SaaS) & Dashboard Development

• Peer-Reviewed Publications

• Logic Models, Summative/Formative Program Evaluations

​​​​

Regulatory:

• Health Canada's Therapeutic Products Directorate (TPD), Natural and Non-prescription Health Products Directorate (NNHPD), Controlled Substances and CNS Branch, Veterinary Drugs Directorate (VDD), Pest Management Regulatory Agency and Associated Guidance Documents/Acts

• U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) and Investigational Device Exemption (IDE) Regulations

• Environmental Protection Agency’s (EPA) Office of Enforcement and Compliance Assurance (OECA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)

• Canada Revenue Agency's Charities Directorate​

• Treasury Board Budget Submissions